Scientific Sessions 2025  /  Shifting Paradigms in Lipid Management for ASCVD Risk  /  Lp(a) and ASCVD: What does the causal link mean for risk reduction in practice?
Logo

American Heart Association

  35
  0

Final ID:

Lp(a) and ASCVD: What does the causal link mean for risk reduction in practice?

  • O'donoghue, Michelle  ( BRIGHAM WOMENS HOSP , BOSTON , Massachusetts , United States )
    • Author Disclosures:
    Michelle O'Donoghue: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen:Active (exists now) ; Consultant:Amgen:Past (completed) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Verve:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Consultant:Janssen:Active (exists now) ; Research Funding (PI or named investigator):Marea:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Shifting Paradigms in Lipid Management for ASCVD Risk

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
Lower LDL-C, for Longer? Defining the Optimal Timing and Intensity of Lipid-Lowering Therapy in Primary Prevention

Blumenthal Roger

The ODYSSEY of Lipid Lowering: Navigating the Growing Array of Therapeutics for LDL-C Reduction

Tokgozoglu Lale

More abstracts from these authors:
The New Guideline in a Global Context: Writing Committee Reply

O'donoghue Michelle, Sandner Sigrid, Tamis-holland Jacqueline

Discussant: LIBerate-OLE, LIBerate-HeFH_OLE

O'donoghue Michelle

You have to be authorized to contact abstract author. Please, Login
Not Available